title: Methylmalonic and propionic acids increase the in vitro incorporation of 32P into cytoskeletal proteins from cerebral cortex of young rats through NMDA glutamate receptors.
abstract: In this study we investigated the effects of methylmalonic acid (MMA) and propionic acid (PA) on the phosphorylation of cytoskeletal proteins of cerebral cortex of rats. Slices of tissue were incubated with 32P-orthophosphate in the presence or absence of glutamate, MMA, PA and ionotropic or metabotropic glutamate receptor agonists. The cytoskeletal fraction was isolated and the radioactivity incorporated into the cytoskeletal proteins was measured. Results demonstrated that the acids, glutamate and NMDA increased the phosphorylation of the proteins studied. However, this effect was not observed for non-NMDA ionotropic agonists or metabotropic agonists. Experiments using glutamate receptor antagonists confirmed that MMA and PA at the same concentrations as found in tissues from propionic or methylmalonic acidemic children increase the phosphorylation of cytoskeletal proteins, possibly via NMDA glutamate receptors. Therefore, it is feasible that these findings may be related to the neurological dysfunction characteristic of these disorders.
authors.affiliation: Universidade Federal do Rio Grande do Sul, Instituto de Ciências Básicas da Saúde, Departamento de Bioquímica, Rua Ramiro Barcelos 2600 anexo, 90035-003, Porto Alegre, Brazil.
authors.forename: A
authors.initials: A
authors.lastname: de Mattos-Dutra
authors.forename: R
authors.initials: R
authors.lastname: Meirelles
authors.forename: B
authors.initials: B
authors.lastname: Bevilaqua da Rocha
authors.forename: T
authors.initials: T
authors.lastname: Kommers
authors.forename: S T
authors.initials: ST
authors.lastname: Wofchuk
authors.forename: M
authors.initials: M
authors.lastname: Wajner
authors.forename: R
authors.initials: R
authors.lastname: Pessoa-Pureur
mesh_terms: D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D018698:Glutamic Acid / Q000494:pharmacology*; D066298:In Vitro Techniques; D008764:Methylmalonic Acid / Q000494:pharmacology*; D016202:N-Methylaspartate / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism*; D010761:Phosphorus Radioisotopes; D010766:Phosphorylation; D011422:Propionates / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology*
chemical_list: D003598:Cytoskeletal Proteins; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D011422:Propionates; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D016202:N-Methylaspartate; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D015763:2-Amino-5-phosphonovalerate; D008764:Methylmalonic Acid; C029658:propionic acid